SEC
SlamSEC
SearchBrowseEarnings

NEVRO CORP

Surgical & Medical Instruments & Apparatus·REDWOOD CITY, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
$406.4M
+5.0% YoY
FY 2024
Adj. EBITDA
$12.3M
3.0% margin
FY 2024
Net Income
$3.0M
0.7% margin
FY 2024
EPS (Diluted)
$0.08
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$120.4M
FY 2024
Total Debt
$211.5M
FY 2024
Net Debt
$91.1M
FY 2024
Enterprise Value
—
Debt / EBITDA
7.4x
FY 2024
EV / EBITDA
—
Employees
—